SHEIKH, SOREN PALUDAN,ANDERSEN, DITTE CAROLINE,JENSEN, CHARLOTTE HARKEN
申请号：
CA3095511
公开号：
CA3095511A1
申请日:
2019.04.03
申请国别(地区):
CA
年份:
2019
代理人:
摘要：
The present invention relates to an isolated CD31+ cell derived from adipose-derived regenerative cells (ADRC's), for use as a medicament. The invention also relates to compositions comprising such cells. In addition, the invention relates to methods for screening for the regenerative capacity of a population of adipose-derived regenerative cells (ADRC's).
